#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4344613	B	Inhibition of Granzyme A (unknown origin) expressed in Pichia pastoris assessed as second- order inhibition rate constant (Kobs/I ratio) pre-incubated with SK15 substrate for 15 mins before enzyme addition by spectrofluorometry	Homo sapiens	2		assay format	Scientific Literature
2.	ALA4344614	B	Inhibition of Granzyme A (unknown origin) expressed in Pichia pastoris using SK15 substrate by spectrofluorometry relative to control	Homo sapiens	2		assay format	Scientific Literature
3.	ALA4344615	B	Inhibition of Granzyme B (unknown origin) expressed in Pichia pastoris using GrBref substrate by spectrofluorometry relative to control	Homo sapiens	2		assay format	Scientific Literature
4.	ALA4344616	B	Inhibition of Granzyme M (unknown origin) expressed in Pichia pastoris using Ac-Lys-Val-Pro-Leu-ACC substrate by spectrofluorometry relative to control	Homo sapiens	2		assay format	Scientific Literature
5.	ALA4344617	B	Inhibition of PR3 (unknown origin) expressed in Pichia pastoris using Ac-Glu(O-Bzl)-Lys(Ac)-Hyp(Bzl)-Nva-ACC substrate by spectrofluorometry relative to control	Homo sapiens	2		assay format	Scientific Literature
6.	ALA4344618	B	Inhibition of human neutrophil elastase expressed in Pichia pastoris using Ac-Arg(NO)2-Glu(Bzl)-Oic-Abu-ACC substrate by spectrofluorometry relative to control	Homo sapiens	2		assay format	Scientific Literature
7.	ALA4344619	B	Inhibition of Granzyme K (unknown origin) expressed in Pichia pastoris using GrKref substrate by spectrofluorometry relative to control	Homo sapiens	2		assay format	Scientific Literature
8.	ALA4344620	B	Binding affinity to Granzyme A (unknown origin) expressed in Pichia pastoris assessed as appearance of fluorescent 35 kDa species at enzyme to probe ratio was 1:1 incubated for 5 mins by SDS-PAGE based in-gel detection method	Homo sapiens	1		assay format	Scientific Literature
9.	ALA4344621	B	Binding affinity to Granzyme A (unknown origin) expressed in Pichia pastoris assessed as minimum concentration needed for GrA labeling at enzyme to probe ratio was 1:1 incubated for 5 to 30 mins by SDS-PAGE based in-gel detection method	Homo sapiens	1		assay format	Scientific Literature
10.	ALA4344622	B	Binding affinity to Granzyme A active form (unknown origin) expressed in Pichia pastoris by Western blot analysis	Homo sapiens	1		assay format	Scientific Literature
11.	ALA4344623	B	Binding affinity to Granzyme A zymogen form (unknown origin) expressed in Pichia pastoris by Western blot analysis	Homo sapiens	1		assay format	Scientific Literature
12.	ALA4344624	B	Binding affinity to Granzyme A active form (unknown origin) expressed in Pichia pastoris at 500 nM in presence of 1 uM methyl 4-[(3S)-3-[[2-[(2S)-2-[(1-diphenoxyphosphoryl-4-guanidinobutyl)carbamoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-2-oxoethyl]carbamoyl]-3,4-dihydro-1H-isoquinolin-2-yl]-4-oxobutanoate by Western blot analysis	Homo sapiens	1		assay format	Scientific Literature
13.	ALA4344625	B	Binding affinity to Granzyme A zymogen form (unknown origin) expressed in Pichia pastoris at 500 nM in presence of 1 uM compound 3 by Western blot analysis	Homo sapiens	1		assay format	Scientific Literature
14.	ALA4344626	B	Binding affinity to Granzyme A in human NK92 cells at 250 nM to 2 uM incubated for 1 hr by SDS-PAGE based in-gel detection assay	Homo sapiens	1		cell-based format	Scientific Literature
15.	ALA4344627	T	Toxicity in human MDA-MB-231 cells assessed as reduction in cell viability at >1 uM incubated for 24 hrs by MTS assay	Homo sapiens	1		cell-based format	Scientific Literature
16.	ALA4344628	T	Toxicity in human MDA-MB-231 cells assessed as reduction in cell viability at <1 uM incubated for 24 hrs by MTS assay	Homo sapiens	1		cell-based format	Scientific Literature
17.	ALA4344630	B	Binding affinity to Granzyme A in human NK92 cells at 1 uM measured 30 mins to 2 hrs post dose by SDS-PAGE analysis	Homo sapiens	1		cell-based format	Scientific Literature
18.	ALA4344631	B	Binding affinity to Granzyme A in human NK92 cells at 1 uM treated 1 hr after GrA covalent inhibitor methyl 4-[(3S)-3-[[2-[(2S)-2-[(1-diphenoxyphosphoryl-4-guanidinobutyl)carbamoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-2-oxoethyl]carbamoyl]-3,4-dihydro-1H-isoquinolin-2-yl]-4-oxobutanoate dosing and measured 30 mins to 2 hrs post dose by SDS-PAGE analysis	Homo sapiens	1		cell-based format	Scientific Literature